Evogene Ltd.
EVGN
$0.76
-$0.02-2.05%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2024 | 09/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -- | -- | -16.49M | -23.51M | -20.28M |
| Total Depreciation and Amortization | -- | -- | 1.38M | 1.60M | 2.59M |
| Total Amortization of Deferred Charges | -- | -- | 471.00K | 137.00K | -- |
| Total Other Non-Cash Items | -- | -- | -2.46M | 2.34M | 398.00K |
| Change in Net Operating Assets | -- | -- | -2.61M | -1.63M | -621.00K |
| Cash from Operations | -- | -- | -19.70M | -21.07M | -17.91M |
| Capital Expenditure | -- | -- | -625.00K | -389.00K | -898.00K |
| Sale of Property, Plant, and Equipment | -- | -- | 10.00K | 10.00K | 26.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | 10.24M | 658.00K | -3.53M |
| Cash from Investing | -- | -- | 9.62M | 279.00K | -4.40M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -886.00K | -788.00K | -1.06M |
| Issuance of Common Stock | -- | -- | 5.62M | 5.67M | 8.43M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -80.00K | -164.00K | 10.58M |
| Cash from Financing | -- | -- | 4.66M | 4.72M | 17.94M |
| Foreign Exchange rate Adjustments | -- | -- | -49.00K | 57.00K | -164.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | -5.47M | -16.01M | -4.53M |